The therapeutic application of IFN-α in cancer, including hairy cell leukemia, lymphoma, renal cell carcinoma, and melanoma, was one of the first successes of immunotherapy [193,194,195]. This evidence concerns the gene IFNA2 and hereditary clear cell renal cell carcinoma.